Gene Therapy Protocols: Edition 2

¡ Methods in Molecular Medicine āĻ•āĻŋāĻ¤āĻžāĻĒ 69 ¡ Springer Science & Business Media
āĻ‡āĻŦā§āĻ•
520
āĻĒā§ƒāĻˇā§āĻ āĻž
āĻŽā§‚āĻ˛ā§āĻ¯āĻžāĻ‚āĻ•āĻ¨ āĻ†ā§°ā§ āĻĒā§°ā§āĻ¯āĻžāĻ˛ā§‹āĻšāĻ¨āĻž āĻ¸āĻ¤ā§āĻ¯āĻžāĻĒāĻ¨ āĻ•ā§°āĻž āĻšā§‹ā§ąāĻž āĻ¨āĻžāĻ‡  āĻ…āĻ§āĻŋāĻ• āĻœāĻžāĻ¨āĻ•

āĻāĻ‡ āĻ‡āĻŦā§āĻ•āĻ–āĻ¨ā§° āĻŦāĻŋāĻˇā§Ÿā§‡

Efforts in gene therapy have grown dramatically in recent years. Basic research as well as clinical activity have made exciting progress and are beg- ning to offer renewed hope that gene therapy may be able to deliver novel approaches for the treatment of inherited as well as such acquired diseases as cardiovascular disease and cancer. With the sequencing of the human genome complete, we now have a comprehensive catalog of genes that further expands the potential role of gene therapy into such new fields as tissue engineering. Central to gene therapy is the process of gene transfer; thus, advances in the technology of gene transfer are at the heart of this field’s progress. Numerous technologies, based on a variety of methods (e.g., viral-mediated, physical/ chemical), have been developed to achieve gene transfer. Some of the earliest methods, such as recombinant retroviruses, are still widely used, have undergone significant improvements, and have given rise to new vectors based on lentiviruses.

āĻāĻ‡ āĻ‡āĻŦā§āĻ•āĻ–āĻ¨āĻ• āĻŽā§‚āĻ˛ā§āĻ¯āĻžāĻ‚āĻ•āĻ¨ āĻ•ā§°āĻ•

āĻ†āĻŽāĻžāĻ• āĻ†āĻĒā§‹āĻ¨āĻžā§° āĻŽāĻ¤āĻžāĻŽāĻ¤ āĻœāĻ¨āĻžāĻ“āĻ•āĨ¤

āĻĒāĻĸāĻŧāĻžā§° āĻ¨āĻŋāĻ°ā§āĻĻā§‡āĻļāĻžā§ąāĻ˛ā§€

āĻ¸ā§āĻŽāĻžā§°ā§āĻŸāĻĢ’āĻ¨ āĻ†ā§°ā§ āĻŸā§‡āĻŦāĻ˛ā§‡āĻŸ
Android āĻ†ā§°ā§ iPad/iPhoneā§° āĻŦāĻžāĻŦā§‡ Google Play Books āĻāĻĒāĻŸā§‹ āĻ‡āĻ¨āĻˇā§āĻŸāĻ˛ āĻ•ā§°āĻ•āĨ¤ āĻ‡ āĻ¸ā§āĻŦāĻ¯āĻŧāĻ‚āĻ•ā§āĻ°āĻŋāĻ¯āĻŧāĻ­āĻžā§ąā§‡ āĻ†āĻĒā§‹āĻ¨āĻžā§° āĻāĻ•āĻžāĻ‰āĻŖā§āĻŸā§° āĻ¸ā§ˆāĻ¤ā§‡ āĻ›āĻŋāĻ‚āĻ• āĻšāĻ¯āĻŧ āĻ†ā§°ā§ āĻ†āĻĒā§āĻ¨āĻŋ āĻ¯'āĻ¤ā§‡ āĻ¨āĻžāĻĨāĻžāĻ•āĻ• āĻ¤'āĻ¤ā§‡āĻ‡ āĻ•ā§‹āĻ¨ā§‹ āĻ…āĻĄāĻŋāĻ…'āĻŦā§āĻ• āĻ…āĻ¨āĻ˛āĻžāĻ‡āĻ¨ āĻŦāĻž āĻ…āĻĢāĻ˛āĻžāĻ‡āĻ¨āĻ¤ āĻļā§āĻ¨āĻŋāĻŦāĻ˛ā§ˆ āĻ¸ā§āĻŦāĻŋāĻ§āĻž āĻĻāĻŋāĻ¯āĻŧā§‡āĨ¤
āĻ˛ā§‡āĻĒāĻŸāĻĒ āĻ†ā§°ā§ āĻ•āĻŽā§āĻĒāĻŋāĻ‰āĻŸāĻžā§°
āĻ†āĻĒā§āĻ¨āĻŋ āĻ•āĻŽā§āĻĒāĻŋāĻ‰āĻŸāĻžā§°ā§° ā§ąā§‡āĻŦ āĻŦā§āĻ°āĻžāĻ‰āĻœāĻžā§° āĻŦā§āĻ¯ā§ąāĻšāĻžā§° āĻ•ā§°āĻŋ Google PlayāĻ¤ āĻ•āĻŋāĻ¨āĻž āĻ…āĻĄāĻŋāĻ…'āĻŦā§āĻ•āĻ¸āĻŽā§‚āĻš āĻļā§āĻ¨āĻŋāĻŦ āĻĒāĻžā§°ā§‡āĨ¤
āĻ‡-ā§°ā§€āĻĄāĻžā§° āĻ†ā§°ā§ āĻ…āĻ¨ā§āĻ¯ āĻĄāĻŋāĻ­āĻžāĻ‡āĻš
Kobo eReadersā§° āĻĻā§°ā§‡ āĻ‡-āĻšāĻŋā§ŸāĻžāĻāĻšā§€ā§° āĻĄāĻŋāĻ­āĻžāĻ‡āĻšāĻ¸āĻŽā§‚āĻšāĻ¤ āĻĒā§āĻŋāĻŦāĻ˛ā§ˆ, āĻ†āĻĒā§āĻ¨āĻŋ āĻāĻŸāĻž āĻĢāĻžāĻ‡āĻ˛ āĻĄāĻžāĻ‰āĻ¨āĻ˛â€™āĻĄ āĻ•ā§°āĻŋ āĻ¸ā§‡āĻ‡āĻŸā§‹ āĻ†āĻĒā§‹āĻ¨āĻžā§° āĻĄāĻŋāĻ­āĻžāĻ‡āĻšāĻ˛ā§ˆ āĻ¸ā§āĻĨāĻžāĻ¨āĻžāĻ¨ā§āĻ¤ā§°āĻŖ āĻ•ā§°āĻŋāĻŦ āĻ˛āĻžāĻ—āĻŋāĻŦāĨ¤ āĻ¸āĻŽā§°ā§āĻĨāĻŋāĻ¤ āĻ‡-ā§°āĻŋāĻĄāĻžā§°āĻ˛ā§ˆ āĻĢāĻžāĻ‡āĻ˛āĻŸā§‹ āĻ•ā§‡āĻ¨ā§‡āĻ•ā§ˆ āĻ¸ā§āĻĨāĻžāĻ¨āĻžāĻ¨ā§āĻ¤ā§° āĻ•ā§°āĻŋāĻŦ āĻœāĻžāĻ¨āĻŋāĻŦāĻ˛ā§ˆ āĻ¸āĻšāĻžāĻ¯āĻŧ āĻ•ā§‡āĻ¨ā§āĻĻā§ā§°āĻ¤ āĻĨāĻ•āĻž āĻ¸āĻŦāĻŋāĻļā§‡āĻˇ āĻ¨āĻŋā§°ā§āĻĻā§‡āĻļāĻžā§ąāĻ˛ā§€ āĻšāĻžāĻ“āĻ•āĨ¤